NCT05367908View on ClinicalTrials.gov

A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

CompletedOBSERVATIONAL

Enrollment

1,501

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

August 14, 2022

Study Completion Date

August 14, 2022

Conditions

SARS-CoV-2

Trial Locations (1)

94402

Evidation Health, San Mateo

All Listed Sponsors

lead

ModernaTX, Inc.

INDUSTRY